re-rating coming

I have been in the stock for some 3 years now with full belief in the product suite assembled and the management team, especially Prof Noam Gavriely.

This appointment is a fundamental change that will only benefit the company in securing sales/distribution partnerships with key global distributors who Mr Eisen will already have had professional working relationships with.

On calling the company and congratulating them on this key appointment I also learnt that an investor presentation is being made around Australia to some of the leading broking houses.......I am sure some will be brokers familiar with the Resmed story and it's growth.

This is an exciting time for all of us who have held and believed.......the future is now a hell of a lot more brighter, good luck to all those that are still on board. I still think we will be a takeover target within the next 12 months.

Well done KSX team!!!!

DYOR